Arafura Rare Earths Extends Wind-Turbine Offtake as Lenders Hold the Key to Nolans

Arafura Rare Earths extended a binding NdPr offtake with a wind-turbine maker, lifting the stock 14% as it seeks financing for its A$1.6bn Nolans project.

Arafura Rare Earths has locked in a fresh commitment from a global wind-turbine manufacturer, extending a binding offtake arrangement that covers up to 500 tonnes of neodymium-praseodymium oxide equivalent (NdPr) per year. The Australian rare-earth developer confirmed the deal today, framing it as another building block on the road to a final investment green light for its Nolans project in the Northern Territory.

Investors greeted the news with a sharp move higher. The stock climbed 14% to EUR 0.1204, a rare bright spot for a share that has otherwise struggled through the year.

Pricing Tied to Global Benchmark Indices

The agreement runs for a fixed five-year term, with an option to stretch it to as long as eight years. Pricing for the NdPr oxide equivalent is denominated in US dollars and tracks established global commodity benchmarks, including Benchmark Minerals Intelligence and S&P Global Platts.

For Arafura, the extension matters most on the funding front. Management says the contract delivers precisely the guaranteed offtake volumes that export credit agencies require before releasing loans. Delivery schedules under the deal are also aligned with the current construction and commissioning timeline at Nolans.

A A$1.6 Billion Bet on Non-Chinese Supply

The A$1.6 billion Nolans development is widely viewed as one of the West's best hopes for building a critical-minerals supply chain independent of China. Arafura announced the final investment decision for the project on 21 May 2026.

By 30 June 2026, the company reported completion of foundational infrastructure works and the assembly of its core workforce. Around the same time, it signed a heads of agreement covering 500 tonnes of magnet feedstock with an Indian special-purpose vehicle.

The wind-turbine contract now extended is unlikely to be the last deal signed before lenders give their full backing. Arafura confirmed that talks over additional offtake agreements with other interested parties are ongoing, and management has signalled that further supply arrangements could mature before the financing package is finalised.

Financing Edifice Built on A$930 Million of Equity

The capital structure rests on a broad base. More than A$930 million in equity has been raised, with backers including strategic partners such as the National Reconstruction Fund Corporation, Export Finance Australia and the German raw-materials fund.

Shareholders ratified key elements of the package at a meeting in July, approving the issue of shares to state-owned Export Finance Australia and KfW, alongside the issuance of convertible notes to the National Reconstruction Fund Corporation.

Roughly two weeks ago, the company offered a glimpse into the state of project financing, which it aims to sign off contractually in October 2026. Final credit approvals from a small number of lenders are still outstanding — a gap that keeps uncertainty alive among market participants until the paperwork is complete.

Offtake Book Already Partly Subscribed

Portions of future output are already spoken for. A binding heads of agreement with Traxys North America covers 500 tonnes of neodymium-praseodymium plus 700 tonnes of dysprosium and terbium. A separate arrangement with an Indian corporate group adds another 500 tonnes of NdPr and seven tonnes of dysprosium and terbium annually. Together, the deals reserve significant tranches of planned production for international buyers.

Years, Not Months, to Full Capacity

Between the upcoming construction milestones and the targeted large-scale output lies a multi-year haul. Once building begins, the erection phase is estimated at 37 months. Early site works in the Northern Territory were already completed back in 2022 to reduce execution risk.

A two-year commissioning and ramp-up period follows construction. Management is targeting first production towards the end of the current decade, with full throughput in steady industrial operation only expected in the years after that.

The market's assessment of those long timelines is reflected in the valuation. The stock closed yesterday at EUR 0.1063, a daily gain of 3.7%, yet it remains down 30% since the start of the year. How the outstanding credit approvals resolve is likely to set the direction from here.